B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent manner - Graalmann, Theresa; Borst, Katharina; Manchanda, Himanshu; Vaas, Lea; Bruhn, Matthias; Graalmann, Lukas; Koster, Mario; Verboom, Murielle; Hallensleben, Michael; Guzmán, Carlos Alberto; Sutter, Gerd; Schmidt, Reinhold E; et al. (Annals of the rheumatic diseases, 2021)
Keywords: Animals; Antibodies; Antirheumatic Agents - adverse effects; Arthritis; Arthritis, Rheumatoid - drug therapy; Autoimmune diseases; B-Lymphocytes; B-Lymphocytes - immunology; Case-Control Studies; CD20 antigen; CD8 antigen; CD8-Positive T-Lymphocytes - immunology; Chemokines; COVID-19; Cytokines; Cytokines - immunology; Cytotoxicity; Histocompatibility Antigens Class I - immunology; Humans; Immunogenicity, Vaccine - immunology; Immunotherapy; Infections; Influenza; Influenza Vaccines - immunology; Influenza Vaccines - therapeutic use; Influenza, Human - prevention & control; Interferon; Interferon Type I - immunology; Lymphocytes; Lymphocytes B; Lymphocytes T; Lymphoma; Major histocompatibility complex; Mice; Monoclonal antibodies; Orthomyxoviridae - immunology; Orthomyxoviridae Infections - immunology; Pandemics; Patients; Rheumatoid; Rheumatoid Arthritis; Rituximab; Rituximab - adverse effects; Severe acute respiratory syndrome coronavirus 2; T-Lymphocyte subsets; Targeted cancer therapy; Vaccination; Vaccines; Vaccinia - immunology; Vaccinia virus - immunology; Viruses; Ankara Turkey; Turkey; Rheumatoid; B-Lymphocytes; Rituximab; T-Lymphocyte subsets; Arthritis; Vaccination